HOME >> BIOLOGY >> NEWS
Flexibility In Cutting Toxic Releases Yields Dividends

CHAMPAIGN, Ill. - Changes in federal regulation giving chemical companies flexibility in deciding how to reduce toxic pollution are producing measurable results, according to researchers at the University of Illinois.

Economists Madhu Khanna and Lisa Damon studied the impact of the 33/50 program started by the Environmental Protection Agency (EPA) in 1991 to encourage firms to reduce their pollution emissions ­ by 33 percent by 1992 and by 50 percent by 1995. The voluntary program gave companies flexibility to determine how to reduce 17 highly toxic chemicals.

The EPA has since hailed the program as a success based on pollution reductions of 46 percent compared with the level shown in the 1988 Toxic Release Inventory.

In their independent sampling of chemical companies, Khanna and Damon found that the EPA's results were inflated by including pollution reductions that took place between 1988 and 1991 before the voluntary program began.

Nevertheless, sampled participants did reduce their overall releases by 41 percent between 1991 and 1993, and had a significantly better record in pollution reduction than chemical companies not participating in the program. The figures were adjusted to equalize size and other variables between participating and non-participating companies.

Their findings suggest that the new environmental initiatives "have been effective in motivating corporations to undertake self-regulated efforts to improve their environmental performance," Khanna and Damon concluded in a paper published by the U. of I. Program in Environmental and Resource Economics.

Moreover, the 33/50 program led to a positive change in the composition of wastes. "Firms have reduced their on-site releases and increased off-site transfers for recycling, energy recovery and treatment. This change is likely to lower the net risks associated with toxic waste generation."

Looking at the question of costs, the researchers found
'"/>

Contact: Mark Reutter
mreutter@uiuc.edu
(217) 333-0568
University of Illinois at Urbana-Champaign
4-Sep-1998


Page: 1 2

Related biology news :

1. Cutting-edge cancer researchers sought for international recognition
2. Cutting back on cigarettes: when less is more
3. AChemS: Cutting edge research in taste, smell, & chemical irritation
4. Cutting edge
5. Cutting-edge research to be presented at ASCPT pharmacology conference
6. Cutting the risk of coronary disease - start before birth says UK doctor
7. Story Tips: Engineering Students Pursue Cutting-Edge Research
8. Brain Building May Depend On DNA Cutting And Pasting
9. Cutting The Time And Cost Of Developing New Cures: Lord Sainsbury Launches Worlds First Biomedical Accelerator Mass Spectrometer In York
10. Gene Shears In Cutting Edge Anti-Aids Trial
11. NIEHS/NTP Director Dr. Kenneth Olden receives Society of Toxicologys Public Communications Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Flexibility Cutting Toxic Releases Yields Dividends

(Date:12/3/2014)... 2, 2014 As part of our commitment ... is pleased to announce the release of a new ... collect the workforce data that they need. ... left by existing readers. Many such devices have serious ... modern technology. Older models force users to navigate numerous ...
(Date:11/21/2014)... YORK , Nov. 19, 2014  Earlier this ... at New York College, and one of the most ... biosensor signals that are transmitted from Smartphones to third ... were Smartphones and has one of the earliest known ... discussing its usage in the military, child care, elder ...
(Date:11/21/2014)... 2014 C-Labs LLC, a leading provider of ... (IoT), today announced the appointment of John Traynor ... a strategic advisor to the firm, Mr. Traynor will ... is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. Photo ...
Breaking Biology News(10 mins):Inception Technologies to Release New Biometric Reader 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... and editorials addressing developments and pathways related to ... provocative article exploring the role of follicle-stimulating hormone ... of prostate cancer. , The article references ... that there could be a connection to prostate ...
(Date:12/19/2014)... 2014 BioPlus Specialty Pharmacy ... the promotion of Nick Maroulis, Pharm.D. to the newly ... , In this position, Dr. Maroulis will continue ... the directors of our multi-site pharmacies as the company ... and during that time he has served in many ...
(Date:12/19/2014)... 2014 Research and Markets ( ... "Technology Innovations in Smart Fabrics (Technical Insights)" ... http://photos.prnewswire.com/prnh/20130307/600769 The Research ... a detailed assessment on technological advancements and market ... 1. The Smart Fabrics market is ...
(Date:12/19/2014)... Reports from CDC show approximately ... one or more chronic health conditions - including cardiovascular ... some of these diseases, but may not eliminate the ... While implanted nerve stimulation devices today offer relief, they ... can induce side effects. , To eliminate the ...
Breaking Biology Technology:Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Technology Innovations in Smart Fabrics (Technical Insights) 2Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2
Cached News: